世界の人工心血管置換装置開発動向:医療機器パイプライン分析2015

◆英語タイトル:Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2015
◆商品コード:GDME0139EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年1月1日
◆ページ数:187
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥404,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥808,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,212,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、人工心血管置換装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・人工心血管置換装置の概要
・人工心血管置換装置の開発動向:開発段階別分析
・人工心血管置換装置の開発動向:セグメント別分析
・人工心血管置換装置の開発動向:領域別分析
・人工心血管置換装置の開発動向:規制Path別分析
・人工心血管置換装置の開発動向:承認日(推定)別分析
・企業別人工心血管置換装置の開発動向(パイプライン製品、進行中の治験)
・人工心血管置換装置の最近動向
【レポートの概要】

Cardiovascular Prosthetic Devices – Medical Devices Pipeline Assessment, 2015

Summary

GlobalData’s Medical Devices sector report, “Cardiovascular Prosthetic Devices – Medical Devices Pipeline Assessment, 2015″ provides an overview of Cardiovascular Prosthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Prosthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiovascular Prosthetic Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiovascular Prosthetic Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiovascular Prosthetic Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 13
2 Introduction 14
2.1 Cardiovascular Prosthetic Devices Overview 14
3 Products under Development 15
3.1 Cardiovascular Prosthetic Devices – Pipeline Products by Stage of Development 15
3.2 Cardiovascular Prosthetic Devices – Pipeline Products by Segment 16
3.3 Cardiovascular Prosthetic Devices – Pipeline Products by Territory 17
3.4 Cardiovascular Prosthetic Devices – Pipeline Products by Regulatory Path 18
3.5 Cardiovascular Prosthetic Devices – Pipeline Products by Estimated Approval Date 19
3.6 Cardiovascular Prosthetic Devices – Ongoing Clinical Trials 20
4 Cardiovascular Prosthetic Devices – Pipeline Products under Development by Companies 21
4.1 Cardiovascular Prosthetic Devices Companies – Pipeline Products by Stage of Development 21
4.2 Cardiovascular Prosthetic Devices – Pipeline Products by Stage of Development 24
5 Cardiovascular Prosthetic Devices Companies and Product Overview 27
5.1 4tech Cardio Ireland Limited Company Overview 27
5.1.1 4tech Cardio Ireland Limited Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Agamit Medical Ltd. Company Overview 29
5.2.1 Agamit Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29
5.3 Ample Medical Inc. Company Overview 30
5.3.1 Ample Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 Amsel Medical Corporation Company Overview 31
5.4.1 Amsel Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Aporo Biomedical, Inc. Company Overview 32
5.5.1 Aporo Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.6 Arbor Surgical Technologies, Inc. Company Overview 35
5.6.1 Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.7 BioStable Science & Engineering, Inc. Company Overview 36
5.7.1 BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.8 BioVentrix, Inc. Company Overview 40
5.8.1 BioVentrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.9 CARAG AG Company Overview 44
5.9.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview 44
5.10 Cardica, Inc. Company Overview 46
5.10.1 Cardica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.11 Cardiosolutions, Inc. Company Overview 49
5.11.1 Cardiosolutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 Cardious, Inc. Company Overview 50
5.12.1 Cardious, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Celyad SA Company Overview 51
5.13.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 Children’s Hospital Boston Company Overview 53
5.14.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 53
5.15 Cierra, Inc. (Inactive) Company Overview 57
5.15.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 CoAptus Medical Corporation Company Overview 58
5.16.1 CoAptus Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 58
5.17 CollPlant Ltd. Company Overview 60
5.17.1 CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
5.18 coramaze technologies GmbH Company Overview 61
5.18.1 coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 61
5.19 Cordis Corporation Company Overview 62
5.19.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 62
5.20 Coroneo Inc. Company Overview 63
5.20.1 Coroneo Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.21 CUBE SRL Company Overview 64
5.21.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 64
5.22 Edwards Lifesciences Corporation Company Overview 65
5.22.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 65
5.23 Emory University Company Overview 72
5.23.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 72
5.24 Guided Delivery Systems, Inc. Company Overview 75
5.24.1 Guided Delivery Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.25 Instituto de investigacion sanitaria Marques de Valdecilla Company Overview 78
5.25.1 Instituto de investigacion sanitaria Marques de Valdecilla Pipeline Products & Ongoing Clinical Trials Overview 78
5.26 IPI Singapore Company Overview 79
5.26.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 79
5.27 Kardium Inc. Company Overview 80
5.27.1 Kardium Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.28 Lartim Medical Ltd Company Overview 81
5.28.1 Lartim Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
5.29 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 82
5.29.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 82
5.30 Mardil Medical, Inc. Company Overview 83
5.30.1 Mardil Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.31 Mayo Clinic. Company Overview 84
5.31.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 84
5.32 Medtentia AB Company Overview 85
5.32.1 Medtentia AB Pipeline Products & Ongoing Clinical Trials Overview 85
5.33 MiCardia Corporation Company Overview 89
5.33.1 MiCardia Corporation Pipeline Products & Ongoing Clinical Trials Overview 89
5.34 Michigan Critical Care Consultants, Inc. Company Overview 92
5.34.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 92
5.35 Middle Peak Medical, Inc Company Overview 94
5.35.1 Middle Peak Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview 94
5.36 Millipede, LLC Company Overview 95
5.36.1 Millipede, LLC Pipeline Products & Ongoing Clinical Trials Overview 95
5.37 Mitral Heal Company Overview 96
5.37.1 Mitral Heal Pipeline Products & Ongoing Clinical Trials Overview 96
5.38 Mitralign, Inc. Company Overview 97
5.38.1 Mitralign, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.39 Mitralix Ltd. Company Overview 105
5.39.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 105
5.40 Mitre Medical Corp. Company Overview 106
5.40.1 Mitre Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview 106
5.41 MValve Technologies Ltd. Company Overview 108
5.41.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 108
5.42 Neochord, Inc. Company Overview 109
5.42.1 Neochord, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
5.43 Occlutech International AB Company Overview 112
5.43.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 112
5.44 Phoenix Cardiac Devices, Inc. Company Overview 119
5.44.1 Phoenix Cardiac Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 119
5.45 QuantumCor Inc. (Inactive) Company Overview 120
5.45.1 QuantumCor Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 120
5.46 ReCor Medical, Inc. Company Overview 121
5.46.1 ReCor Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
5.47 SCR, Inc. Company Overview 124
5.47.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.48 SeptRx, Inc. Company Overview 125
5.48.1 SeptRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125
5.49 Sorin S.p.A. (Inactive) Company Overview 128
5.49.1 Sorin S.p.A. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128
5.50 St. Jude Medical, Inc. Company Overview 130
5.50.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.51 Sutura, Inc. (Inactive) Company Overview 137
5.51.1 Sutura, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 137
5.52 Swissimplant AG (Inactive) Company Overview 139
5.52.1 Swissimplant AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139
5.53 The Tel Aviv Sourasky Medical Center Company Overview 141
5.53.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 141
5.54 TransCardiac Therapeutics, LLC Company Overview 142
5.54.1 TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 142
5.55 Trinity College Dublin Company Overview 143
5.55.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 143
5.56 University of Minnesota Company Overview 144
5.56.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 144
5.57 Valcare Medical Company Overview 145
5.57.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 145
5.58 Valtech Cardio Ltd. Company Overview 146
5.58.1 Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 146
5.59 Viacor, Inc. Company Overview 153
5.59.1 Viacor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 153
5.60 Vir(Sn), Inc. Company Overview 156
5.60.1 Vir(Sn), Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.61 W. L. Gore & Associates, Inc. Company Overview 157
5.61.1 W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
6 Cardiovascular Prosthetic Devices- Recent Developments 162
7 Appendix 184
7.1 Methodology 184
7.2 About GlobalData 186
7.3 Contact Us 187
7.4 Disclaimer 187

1.1 List of Tables
Table 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 15
Table 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment 16
Table 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory 17
Table 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 18
Table 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 19
Table 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 20
Table 7: Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development 21
Table 8: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 24
Table 9: 4tech Cardio Ireland Limited Pipeline Products & Ongoing Clinical Trials Overview 27
Table 10: TriCinch System - Product Status 28
Table 11: TriCinch System - Product Description 28
Table 12: Agamit Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 13: Device For Mitral Valve Repair - Product Status 29
Table 14: Device For Mitral Valve Repair - Product Description 29
Table 15: Ample Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 16: PS3 System - Product Status 30
Table 17: PS3 System - Product Description 30
Table 18: Amsel Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 31
Table 19: Amsel Occluder Device - Percutaneous Procedures - Product Status 31
Table 20: Amsel Occluder Device - Percutaneous Procedures - Product Description 31
Table 21: Aporo Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 22: Patent Foramen Ovale Closure Device - Product Status 32
Table 23: Patent Foramen Ovale Closure Device - Product Description 32
Table 24: Aporo Biomedical, Inc. - Ongoing Clinical Trials Overview 33
Table 25: Patent Foramen Ovale Closure Device - Prospective Clinical Follow-up of Patients Presenting With Cryptogenic Stroke Treated With the Percutaneous Closure of a Patent Foramen Ovale 34
Table 26: Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 27: Trilogy Attachment Clip - Product Status 35
Table 28: Trilogy Attachment Clip - Product Description 35
Table 29: BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 30: HAART 200 Annuloplasty Device - Product Status 36
Table 31: HAART 200 Annuloplasty Device - Product Description 36
Table 32: HAART 300 Annuloplasty Device - Product Status 37
Table 33: HAART 300 Annuloplasty Device - Product Description 37
Table 34: BioStable Science & Engineering, Inc. - Ongoing Clinical Trials Overview 38
Table 35: HAART 200 Annuloplasty Device - HAART 200 Aortic Valve Annuloplasty During Bicuspid Aortic Valve Reconstruction 39
Table 36: BioVentrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 37: Revivent-TC System - Product Status 41
Table 38: Revivent-TC System - Product Description 41
Table 39: BioVentrix, Inc. - Ongoing Clinical Trials Overview 42
Table 40: Revivent-TC System - Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy 43
Table 41: CARAG AG Pipeline Products & Ongoing Clinical Trials Overview 44
Table 42: Solysafe Septal Occluder - Degradable Version - Product Status 45
Table 43: Solysafe Septal Occluder - Degradable Version - Product Description 45
Table 44: Cardica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
Table 45: Cardica Mitral Repair - Product Status 47
Table 46: Cardica Mitral Repair - Product Description 47
Table 47: PFO Closure Device - Product Status 48
Table 48: PFO Closure Device - Product Description 48
Table 49: Cardiosolutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 50: Mitra-Spacer - Product Status 49
Table 51: Mitra-Spacer - Product Description 49
Table 52: Cardious, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 53: AvA Aortic Valve Bypass Graft System - Product Status 50
Table 54: AvA Aortic Valve Bypass Graft System - Product Description 50
Table 55: Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 51
Table 56: Cardiao3 Closure Device - Product Status 52
Table 57: Cardiao3 Closure Device - Product Description 52
Table 58: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 53
Table 59: Endovascular Prosthesis - Product Status 54
Table 60: Endovascular Prosthesis - Product Description 54
Table 61: Mitral Valve Repair Clip - Product Status 55
Table 62: Mitral Valve Repair Clip - Product Description 55
Table 63: Tricuspid Valve Repair Device - Product Status 56
Table 64: Tricuspid Valve Repair Device - Product Description 56
Table 65: Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
Table 66: PFx Closure System - Product Status 57
Table 67: PFx Closure System - Product Description 57
Table 68: CoAptus Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 58
Table 69: Non-Implant Therapeutic Catheter Device - Product Status 59
Table 70: Non-Implant Therapeutic Catheter Device - Product Description 59
Table 71: CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 72: VergenixHVR - Product Status 60
Table 73: VergenixHVR - Product Description 60
Table 74: coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 61
Table 75: Mitramaze Valve Repair System - Product Status 61
Table 76: Mitramaze Valve Repair System - Product Description 61
Table 77: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 62
Table 78: SeptRx PFO - Product Status 62
Table 79: SeptRx PFO - Product Description 62
Table 80: Coroneo Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
Table 81: Extra-Aortic Annuloplasty Ring - Product Status 63
Table 82: Extra-Aortic Annuloplasty Ring - Product Description 63
Table 83: CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 64
Table 84: Mitral-FERCube Ring - Product Status 64
Table 85: Mitral-FERCube Ring - Product Description 64
Table 86: Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 65
Table 87: Coapsys - Product Status 66
Table 88: Coapsys - Product Description 66
Table 89: FORMA Tricuspid Repair System - Product Status 67
Table 90: FORMA Tricuspid Repair System - Product Description 67
Table 91: MOBIUS Leaflet Repair System - Product Status 68
Table 92: MOBIUS Leaflet Repair System - Product Description 68
Table 93: MONARC Mitral Repair System - Product Status 69
Table 94: MONARC Mitral Repair System - Product Description 69
Table 95: Edwards Lifesciences Corporation - Ongoing Clinical Trials Overview 70
Table 96: Coapsys - Valvular And Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study 71
Table 97: Emory University Pipeline Products & Ongoing Clinical Trials Overview 72
Table 98: MitraPlug - Product Status 73
Table 99: MitraPlug - Product Description 73
Table 100: MitraSurg - Product Status 74
Table 101: MitraSurg - Product Description 74
Table 102: Guided Delivery Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
Table 103: GDS Accucinch System - Product Status 75
Table 104: GDS Accucinch System - Product Description 75
Table 105: Guided Delivery Systems, Inc. - Ongoing Clinical Trials Overview 76
Table 106: GDS Accucinch System - A Study of Percutaneous Left Ventricular Reshaping of Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve LV Function Using the Accucinch System 77
Table 107: GDS Accucinch System - Clinical Protocol - A Feasibility Study Using the Accucinch System in the Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function 77
Table 108: Instituto de investigacion sanitaria Marques de Valdecilla Pipeline Products & Ongoing Clinical Trials Overview 78
Table 109: Myocardial Bioactive Implant - Product Status 78
Table 110: Myocardial Bioactive Implant - Product Description 78
Table 111: IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 79
Table 112: PFO Occluder - Product Status 79
Table 113: PFO Occluder - Product Description 79
Table 114: Kardium Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
Table 115: Percutaneous Mitral Valve Regurgitation Device - Product Status 80
Table 116: Percutaneous Mitral Valve Regurgitation Device - Product Description 80
Table 117: Lartim Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
Table 118: Mitral Valve Repair Device - Product Status 81
Table 119: Mitral Valve Repair Device - Product Description 81
Table 120: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 82
Table 121: Absorbable Occluder - Product Status 82

1.2 List of Figures
Figure 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 15
Figure 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment 16
Figure 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory 17
Figure 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 18
Figure 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 19
Figure 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 20

【掲載企業】

4tech Cardio Ireland Limited
Agamit Medical Ltd.
Ample Medical Inc.
Amsel Medical Corporation
Aporo Biomedical, Inc.
Arbor Surgical Technologies, Inc.
BioStable Science & Engineering, Inc.
BioVentrix, Inc.
CARAG AG
Cardica, Inc.
Cardiosolutions, Inc.
Cardious, Inc.
Celyad SA
Children's Hospital Boston
Cierra, Inc. (Inactive)
CoAptus Medical Corporation
CollPlant Ltd.
coramaze technologies GmbH
Cordis Corporation
Coroneo Inc.
CUBE SRL
Edwards Lifesciences Corporation
Emory University
Guided Delivery Systems, Inc.
Instituto de investigacion sanitaria Marques de Valdecilla
IPI Singapore
Kardium Inc.
Lartim Medical Ltd
Lifetech Scientific (Shenzhen) Co., Ltd.
Mardil Medical, Inc.
Mayo Clinic.
Medtentia AB
MiCardia Corporation
Michigan Critical Care Consultants, Inc.
Middle Peak Medical, Inc
Millipede, LLC
Mitral Heal
Mitralign, Inc.
Mitralix Ltd.
Mitre Medical Corp.
MValve Technologies Ltd.
Neochord, Inc.
Occlutech International AB
Phoenix Cardiac Devices, Inc.
QuantumCor Inc. (Inactive)
ReCor Medical, Inc.
SCR, Inc.
SeptRx, Inc.
Sorin S.p.A. (Inactive)
St. Jude Medical, Inc.
Sutura, Inc. (Inactive)
Swissimplant AG (Inactive)
The Tel Aviv Sourasky Medical Center
TransCardiac Therapeutics, LLC
Trinity College Dublin
University of Minnesota
Valcare Medical
Valtech Cardio Ltd.
Viacor, Inc.
Vir(Sn), Inc.
W. L. Gore & Associates, Inc.

【レポートのキーワード】

人工心血管置換装置

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界の人工心血管置換装置開発動向:医療機器パイプライン分析2015]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年09月26日現在 207,216 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆